GSK Investigational Site

Bagno A Ripoli (FI), Tuscany 50126

0 studies enrolling now · 5 studies all time

What they study most

HIV Infections, HIV-1 Infection, Infection, Human Immunodeficiency Virus, Infection, Human Immunodeficiency Virus I, Prostatic Hyperplasia

Studies at this site

• Dolutegravir Expanded Access Study — Completed
• A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial) — Completed
• A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults — Stopped early
• Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment — Completed
• A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen. — Completed